01606nas a2200385   4500000000100000008004100001260001300042653001000055653001200065653002400077653001800101653001100119653001000130653002700140653002900167653002300196653001200219653000900231653002000240653003000260653002100290653001900311100001200330700001200342700001400354700001600368700001300384245011500397856005100512300001200563490000700575050003200582520059200614022001401206       2004                            d  c2004 Dec10aAdult10aAnimals10aDisease Progression10aFatal Outcome10aHumans10aIleus10aImmunocompromised Host10aImmunosuppressive Agents10aLeprostatic Agents10aleprosy10aMale10aRisk Assessment10aStrongyloides stercoralis10aStrongyloidiasis10aSuperinfection1 aLeang B1 aLynen L1 aTootill R1 aGriffiths S1 aMonchy D00aDeath caused by strongyloides hyperinfection in a leprosy patient on treatment for a type II leprosy reaction.  uhttps://leprosyreview.org/article/75/4/39-8403  a398-4030 v75  aInfolep Library - available3 a<p>Strongyloides stercoralis is present worldwide and can cause hyperinfection in patients on long-term immunosuppressive doses of steroids, as is sometimes the case for patients treated for leprosy reactions. Strongyloides hyperinfection can present with ileus, as is discussed in this case report. Physicians, including surgeons, should be aware of this entity in order to avoid an unnecessary laparotomy. Though patients may survive if diagnosed at an early stage, strongyloides hyperinfection syndrome has a mortality rate of 87% and prevention is therefore of utmost importance.</p>  a0305-7518